The dopamine D2 receptor (D2R) has been used in adenoviral delivery systems and in tumor cell xenografts as an in vivo reporter gene. D2R reporter gene expression has been non-invasively, repetitively and quantitatively imaged by positron emission tomography
Introduction
Use of reporter genes to monitor the location, magnitude and duration of gene expression has played a major role in advancing our understanding of many biological processes. However, most reporter gene systems (eg ␤-galactosidase, chloramphenicol acetyl transferase) require that cells or tissues be disrupted for biochemical analysis. Secreted reporter gene products (eg growth hormone) permit non-invasive, repetitive measures of the level and duration of reporter gene expression in living animals, but cannot determine the cellular/tissue source of reporter gene expression.
Non-invasive optical techniques for monitoring firefly luciferase 1, 2 and green fluorescent protein (GFP) [3] [4] [5] expression in living animals have been developed and applied to in vivo gene transfer models. Luciferase and GFP in vivo imaging techniques provide the advantages of non-invasive and repetitive monitoring of reporter gene expression in living animals, but are primarily qualitative/semi-quantitative and do not provide tomo-graphic images. In addition, optically based techniques for monitoring reporter gene expression cannot easily be extrapolated for clinical use.
Molecular biology techniques are now being merged with nuclear medicine [6] [7] [8] [9] [10] [11] [12] procedures, to develop reporter genes for in vivo use in both animal and human subjects. These approaches utilize reporter genes whose protein products sequester radionuclide-labeled compounds. Positron emission tomography (PET) provides quantitative, sensitive and efficient tomographic imaging that can simultaneously examine all tissues. 13 PET imaging probes, used in nanomole/picomole per gm concentrations, do not disturb the process under study. Studies performed in small animals with the microPET scanner 14, 15 can be extrapolated to patients, using clinical PET scanners.
Two in vivo radionuclide-based reporter gene approaches have been used: enzyme-based reporter genes whose products convert radionuclide-labeled substrates to trapped products and receptor-based reporter genes whose products bind radionuclide-labeled ligands. Herpes simplex virus type 1 thymidine kinase (HSV1tk) has been the most widely exploited enzyme-based reporter gene whose expression is detected by radionuclide product sequestration. HSV1tk can phosphorylate a number of compounds that cannot be phosphoryl-ated by endogenous mammalian TK enzymes. If radionuclide-labeled HSV1tk substrates are used to detect HSV1tk expression, retention of the HSVtk-dependent product in cells and tissues can be monitored with radionuclide imaging procedures. Intravenously administered, positron-labeled acycloguanosine substrates for HSV1tk 6, 7 and systemically delivered positron-labeled thymidine analogues 8 have been used to monitor the location and magnitude of HSV1tk expression in living animals by PET, both following somatic gene delivery 9 and as a transgene. 7 For acycloguanosine substrates, the efficacy of the HSV1tk PET reporter gene imaging system has been improved by site-directed mutagenesis to create HSV1tk enzymes with both greater affinity for positronlabeled substrates and reduced affinity for thymidine. 10 Two receptor-based reporter genes have been described that utilize radionuclide detection. The dopamine D2 receptor (D2R) is expressed primarily in the striatum. We used the D2R as a PET reporter gene, both in an adenoviral delivery vector and in stably transfected tumor cell xenografts. The location, magnitude and duration of D2R reporter gene expression can be monitored by microPET detection of D2R-dependent sequestration of systemically-injected 3-(2Ј-[ The somatostatin type 2 receptor (SSTr2) is expressed primarily in the pituitary. When used as a reporter gene, the location of SSTr2 expression can be monitored by systemic injection of a technetium-99 labeled SSTr2 peptide ligand ( 99m Tc-P829) and subsequent imaging by planar imaging techniques with a conventional gamma camera. 12 One potential problem with receptor-based PET reporter genes is the possibility that ectopic receptor gene expression could change target cell physiology. While administration of imaging ligand (eg FESP, 99m Tc-P829) is unlikely to have a biological effect, because of the low mass levels of radiolabeled probe used for reporter gene detection and the transient exposure to the labeled probes, circulating endogenous ligands for these ectopically expressed receptors might constitute a chronic stimulus provoking undesired biological responses. The primary response evoked by dopamine binding to the dopamine D2 receptor is the activation of a Gi-protein complex that leads to inactivation of adenylyl cyclase and a consequent decrease in cellular cyclic AMP levels. Fortunately, two mutations have been described [16] [17] [18] that uncouple ligand binding of the dopamine D2 receptor to activation of the G␣i subunit of the Gi-protein complex signaling pathway that suppresses cyclic AMP synthesis in cells. We have investigated the utility of these two mutated D2R genes as PET reporter genes.
Results

Generation of two mutated dopamine D2 receptors
Our goal in these studies is to create mutant D2R receptors that can be used to image gene expression, but which will not modulate cell function. Two mutations have been reported to uncouple ligand binding from subsequent D2R-mediated inhibition of cyclic AMP accumulation in cells. [16] [17] [18] Using standard site-directed mutagenesis procedures, we created cDNAs with the codon replacements D2R80A and D2R194A, shown in Figure 1 . In D2R80A, codon 80 was changed from GAT (Asp) to GCT (Ala); in D2R194A, codon 194 was switched from TCC (Ser) to GCC (Ala). The coding sequences of D2R80A and D2R194A were validated by DNA sequencing; no other mutations were created. To initially evaluate the ligand binding of these two mutant D2R receptors, the D2R80A and D2R194A cDNA sequences were cloned into the mammalian expression vector pACCMVpLpASR(+) under the regulation of the CMV promoter.
The D2R80A dopamine D2R mutant binds [
3 H]spiperone, but does not modulate cyclic AMP production in stably transfected cells Stable clones expressing the D2R, D2R80A or D2R194A receptors from the CMV promoter were established in C6 cells, using the pACCMVpLpASR(+) vectors described above. Northern blot analysis was used to identify stable clones that express the D2R, D2R80A and D2R194A genes. To determine initially whether these mutations have major effects on ligand binding or cAMP production, three clones that express substantial levels of D2R mRNA were selected (Figure 2a ). The ability of these stably transfected cell lines, expressing D2R, D2R80A or D2R194A mRNA, to bind [ To examine dopamine D2 receptor-mediated inhibition of cAMP production, stably transfected cells expressing D2R, D2R80A or D2R194A were treated both with forskolin to stimulate cAMP accumulation and with dopamine. 19 In control C6 cells, which express little or no D2R, forskolin induces cAMP accumulation, and dopamine (10 m) has no effect ( Figure 2c ). In contrast, in C6 cells expressing the wild-type D2R, dopamine showed a strong inhibitory effect on cAMP accumulation, blocking 80% of the forskolin-induced elevation in cAMP. In contrast, binding of dopamine to mutant D2R80A in C6-stb-D2R80A cells failed to inhibit adenylyl cyclase activity; cAMP accumulation levels induced by forskolin were unaffected by dopamine treatment and remained high. In C6-stb-D2R194A cells, cAMP accumulation stimulated by forskolin was reduced slightly, to 83%, in the presence of dopamine. While substantially reduced, the inhibitory effect of ligand-activated D2R194A on cAMP accumulation is statistically significant. The data suggest that binding of dopamine may stimulate some residual signaling activity linking the mutant D2R194A receptor to the Gi-protein signaling system inhibiting adenylyl cyclase. 
Binding of dopamine to the D2R80A mutant receptor expressed from a non-replicating adenovirus does not inhibit cyclic AMP accumulation in infected cells
Using methods we have described previously, 9-11 we constructed non-replicating adenoviruses expressing, from the CMV promoter, either the D2R80A or the D2R194A mutant D2R cDNAs. All viruses used in this study are shown in Figure 3 ; their construction is described in Materials and methods. The two adenoviruses ad.D2R80A and ad.D2R194A are otherwise identical to the non-replicating adenovirus ad.D2R.
11 (In Ref. 11 the orientation of the CMV-D2R cassette is shown, incorrectly, in the right to left orientation.) C6 cells infected by these three adenoviruses produce substantial levels of mRNA for the three forms of the dopamine D2 receptor (Figure 4a ).
We next examined the ability of the three forms of the dopamine D2 receptor, expressed following adenovirus infection, to modulate the levels of cAMP in C6 cells. These results are very similar to the results we observed in C6 cells stably transfected with D2R receptor plasmids ( Figure 2c ). In cells infected with a control adenovirus, dopamine treatment has no modulatory effect on forskolin-stimulated cAMP accumulation (Figure 4b, left panel) . In contrast, following infection with ad.D2R, dopamine administration dramatically reduces forskolin-stimulated cAMP accumulation (Figure 4b, second panel) Figure 5 ). These data demonstrate that uncoupling of ligand activation of the inhibitory G-protein in the D2R80A dopamine D2 receptor mutant does not alter the receptor's spiperone-binding affinity.
The D2R80A dopamine D2R receptor mutant and wildtype D2R function equally well as PET reporter genes in vivo
We have previously used cells stably transfected with bicistronic vectors to demonstrate the correlation between expression of two PET reporter genes in the same animal. 20 To compare the efficacy of the D2R80A dopamine D2 receptor mutant with the wild-type D2R, we created adenoviruses expressing two different bicistronic vectors. In the first adenovirus vector, ad.DTm, we placed the wild-type D2R cDNA proximal to the encephalomyocarditis virus (EMCV) internal ribosomal entry site (IRES), and the HSV1-sr39tk gene distal to the IRES. The second adenovirus, ad.DaTm, was identical to ad.DTm, with the exception that the mutant D2R80A coding sequence replaced the D2R coding sequence of ad.DTm. In both viruses, the CMV promoter drives expression of the bicistronic messages. By measuring the expression of the D2R and D2R80A PET reporter genes in the microPET with FESP 11 and subsequently, the expression of the HSV1-sr39tk PET reporter gene with FHBG ) Since both the D2R reporter genes and the HSV1-sr39tk PET reporter gene are located in the same transcript, the ratios of the FESP %ID/g liver to the FHBG %ID/g liver provide an internally controlled comparison of the ability of the wild-type D2R and the mutant D2R80A receptors to serve as PET reporter genes. For mice injected with ad.DTm, which express the wildtype D2R, the ratio of FESP/FHBG is 2.0 ± 0.3. For mice injected with ad.DaTm, which express the D2R80A mutant D2R, the FESP/FHBG ratio is 2.1 ± 0.3. Statistically, the FESP/FHBG ratios between mice infected with ad.DTm and mice infected with ad.DaTm show no significant difference. We conclude that the D2R80A mutant of the dopamine D2 receptor is as effective a PET reporter gene as the wild-type D2R. 
Figure 6 Comparison by microPET analysis of the in vivo FESP-binding activities of D2R and D2R80A, using adenoviruses that express the dopamine D2 receptors and the HSV1-sr39tk reporter gene from bicistronic vectors. Mice were injected via the tail vein with 2 × 10 9 p.f.u. of ad.v (left images), ad.DTm (center images) or ad.DaTm (right images). Two days later, the mice were injected with FHBG and scanned by microPET to image HSV1-sr39tk reporter gene expression. The following day, the same mice were injected with FESP and scanned by microPET to image expression of the D2R or D2R80A reporter gene expression. (a) Coronal FESP microPET images for mice injected with the three adenoviruses. (b) FHBG images for mice injected with the three adenoviruses. (c) FESP percent injected dose per g of liver and FHBG percent injected dose per
Discussion
One of the major disadvantages of using genes encoding endogenous receptors as in vivo reporter genes is the possibility that ectopic gene expression can modulate the biology of the targeted cells. Reporter gene modulation of cell function may not be an issue in gene transfer protocols in which the therapeutic endpoint is rapid cell killing of the targeted cell, eg in cancer therapy. Where longterm analysis of reporter gene expression is the goal, however, such as in replacement gene therapy or transgenic analysis of gene expression in experimental animals, reporter gene modulation of biological function could have profound effects on cells, tissues and organisms.
The reporter genes used to date for radionuclide-based in vivo imaging have alternative advantages and disadvantages. A substantial literature exists on ectopic HSV1tk expression in animal models and human cancer therapy clinical trials, because of the potential ability to use HSV1tk as a therapeutic modality to locally activate prodrug acycloguanosines to toxic molecules. [23] [24] [25] As a result, we know more about ectopic expression of this reporter gene than other systems. Because HSV1tk is a 'foreign' gene, HSV1tk protein may be immunogenic. Reporter gene immunogenicity may lead to cell killing or reduced reporter gene expression over time. Thymidine metabolism by ectopically expressed HSV1tk may also have some biological consequences. Because current TK substrates cannot pass the blood-brain barrier, HSV1tk cannot be used to image reporter gene expression in brain, unless some method of permeabilizing the barrier is employed or in applications in which the blood-brain barrier is compromised (eg brain tumors). Nevertheless, it may be possible to use TK both as an imaging gene and as a therapeutic gene in the same individual, to both monitor and treat tumors. Because of its extensive use and consequent familiarity in cell biology, HSV1tk will certainly play a prominent role in development and exploitation of in vivo reporter gene imaging.
The somatostatin type 2 receptor (SST2R) was used as a reporter gene to monitor adenoviral delivery, 12 using a technetium-99 m -labeled SST2 peptide ligand and planar gamma camera imaging. SST2R activation leads to cell cycle arrest and reduced cell proliferation. 26 This property may reduce the potential of the SST2R as a reporter gene, since endogenous ligands may induce undesirable alterations in proliferation or other responses in cells expressing an ectopic SST2R. Uncoupling ligand binding and signal activation may also be useful in optimizing SST2R as an in vivo reporter gene.
The only report of a successful in vivo system for imaging reporter gene expression with magnetic resonance 27 requires receptor-driven internalization of the reporting ligand -iron-bound transferrin -to accumulate sufficient reporter to produce a signal. Ectopic overexpression of the transferrin receptor and accumulation of large amounts of superparamagnetic nanoparticles during the imaging process have the same potential consequences that our studies with the mutated D2R are designed to avoid, that ectopic receptor gene expression could change target cell physiology.
Chronic reduction of cAMP levels as a result of endogenous activation of the dopamine D2 receptor and consequent G␣i-mediated inhibition of adenylyl cyclase activity might well interfere with a variety of local and systemic biological functions. Using both transfected cells and cells infected with adenovirus expressing the D2R80A receptor, we find that ligand binding for the D2R80A mutation is completely uncoupled from modulating cAMP; stimulation with dopamine has no effect on cAMP levels. Mutation of serine 194 in the dopamine D2 receptor is reported to have little or no effect on spiperone binding. 18 The S194A mutated receptor, stably expressed in transfected C6 cells, was unable to inhibit hormone-stimulated elevation of cyclic AMP accumulation in response to dopamine stimulation. 18 While we find that mutation of serine 194 to alanine substantially reduces the signaling capacity of the dopamine D2 receptor, we still detect a modest ability of the D2R194A mutant receptor to modulate cAMP levels. Since preliminary binding data suggested that there is not much difference in the ability of the two mutant D2R receptors to bind [ 3 H]spiperone, we have examined more fully the ability of the D2R80A mutant receptor to bind ligand and to function as a PET reporter gene in vivo.
In comparing the [ 3 H]spiperone in vitro binding studies for the wild-type D2R versus the D2R80A mutation, our data suggest that D2R80A is equally effective at binding this ligand, despite the complete uncoupling of ligandbinding and activation of the Gi-protein system for this mutant. The D2R80A dopamine receptor mutation effectively uncouples ligand binding and ligand-stimulated signaling, as previously suggested, 16 but does not reduce the efficacy of this mutated D2R receptor as a PET reporter gene. The D2R194A mutant receptor can also serve as an equally effective PET reporter gene, in vivo, following adenovirus administration and imaging with FESP (data not shown). Because the D2R80A mutation appears, in our hands, to be more effectively uncoupled from ligand-dependent signaling (Figures 2c and 4b) , we have chosen to emphasize the D2R80A mutant dopamine receptor for future applications of this PET reporter gene imaging system.
We have now described two robust, reliable PET reporter gene/PET reporter probe systems in which we have generated 'second generation' PET reporter genes with site-directed mutations and identified optimized PET reporter probes: (1) the dopamine D2R80A receptor as PET reporter gene and FESP as the PET reporter probe; and (2) the HSV1-sr39tk mutated thymidine kinase as PET reporter gene and FHBG, a side-chain labeled penciclovir derivative, as the corresponding PET reporter probe. The two PET reporter gene/PET reporter probe systems can be used individually to monitor transgene expression in experimental animals [9] [10] [11] and in bicistronic vectors with potential therapeutic genes in somatic gene transfer vectors (Ref. 20 and Figure 6a and b) . The two in vivo reporter gene systems also provide an opportunity to monitor differences in location, magnitude and duration of gene expression in individuals, following simultaneous delivery of control and redirected viral vectors or simultaneous delivery of vectors containing alternative promoter constructs. Both the D2R80A and HSV1-sr39tk reporter genes can, with proper modifications of the ligand/substrate reporter probes, be used for autoradiographic, gamma camera and/or single photon emission tomography imaging studies. Ci/mmol) were synthesized and purified as described previously. 21 Glass microfiber filters (GF/F) were obtained from Whatman (Clifton, NJ, USA). Dopamine and forskolin were from Sigma (St Louis, MO, USA).
Materials and methods
Materials
Generation and expression of dopamine D2 receptor mutants
Rat dopamine D2 receptor mutants were generated by PCR-mediated site-directed mutagenesis, using the overlap extension method 28, 29 with the expanded high fidelity PCR system from Boehringer Mannheim (Indianapolis, IN, USA). The overlapping mutagenic primers used to replace aspartic acid with alanine at amino acid 80 of the rat D2 receptor are 5Ј-TGCTGTGGCTGCTCTTCTGG TGGCCAC-3Ј and 5Ј-GTGGCCACCAGAAGAGCAG CCACAGCA-3Ј. The overlapping mutagenic primers used to replace serine with alanine at amino acid 194 are 5Ј-GTGGTCTACTCCGCCATTGTCTCATTCT-3Ј and 5Ј-AGAATGAGACAATGGCGGAGTAGACCAC3Ј. D2R-up (5Ј-AGAATTCTGAAG AGCCGTGCCACCCAG-3Ј) and D2R-dn (5Ј-CAAGCTTGGAAGCAGCTGCTG TGCAGG-3Ј) are the pair of flanking primers of the full length of D2R cDNA coding sequence. The resulting mutated DNA fragments were cloned into pCRII vector (Invitrogen, Carlsbad, CA, USA), and analyzed by DNA sequencing to confirm the desired mutation. Finally, the full length coding regions of the mutated D2R cDNAs and the wild-type D2R sequence were subcloned into the pcDNA3.1(−) and pACCMVpLpASR(+)30 mammalian expression vectors via the unique EcoRI and HindIII restriction sites.
Construction and purification of recombinant nonreplicating adenoviruses
The mutated D2R sequences were excised from pCRII.D2R80A and pCRII.D2R194A and cloned into the adenoviral shuttle vector pACCMVpLpASR(+). The resulting two plasmids were named as pACCMV.D2R80A and pACCMV.D2R194A. To make IRES bi-cistronic expression constructs in adenovirus, the insert of [D2R-IRES-sr39TK] in pcDNA.D2R-IRES-sr39TK 20 was excised and cloned into pACCMVpLpASR(+) via the unique BamHI and XbaI sites. The resulting shuttle vector was designated as pACCMV.DTm. The wild-type D2R cDNA in pACCMV.DTm was subsequently replaced with the D2R80A cDNA via the EcoRI sites located at both ends of the D2R coding region, to generate pACCMV.DaTm. Each of these four recombinant shuttle vectors was cotransfected with Ad5 genome plasmid pJM17 (Microbix Biosystems Inc, Ontario, Canada) into 293 cells, using the calcium phosphate precipitation method. 31 Plaques of recombinant adenoviruses produced via in vivo homologous recombination were isolated and purified by three cycles of purification. [9] [10] [11] Restriction mapping of viral genomic DNA confirmed that the correct recombinant adenoviruses had been constructed. After confirming D2R, D2R80A and D2R194A gene expression by [ 3 H]spiperone binding, high titer viral stocks for each recombinant adenovirus were prepared. The resulting four adenoviruses were named as ad.D2R80A (expressing the D2R80A receptor from the CMV promoter), ad.D2R194A (expressing the D2R194A receptor from the CMV promoter), ad.DTm (expressing, in a bi-cistronic message, the wild-type D2R from the CMV promoter proximal to the ECMV IRES and HSV1-sr39tk distal to the IRES), and ad.DaTm (expressing, in a bi-cistronic message, the D2R80A receptor from the CMV promoter proximal to the ECMV IRES and HSV1-sr39tk distal to the IRES). A control recombinant adenovirus (ad.v) was also produced by co-transfection of pACCMVpLpASR(+) and pJM17 on 293 cells. The ad.D2R adenovirus (expressing the wild-type D2R from the CMV promoter) was described previously. 10, 11 The expression constructs of the six replication-deficient type 5 adenoviruses used in these experiments are illustrated in Figure 3 .
Cell culture and establishment of stable transfected clones 293 Cells and rat C6 glioma cells were cultured in DME high glucose medium (Life Technologies, Grand Island, NY, USA) containing 10% fetal bovine serum (Life Technologies), 0.2 mm glutamine, 110 mg/l sodium pyruvate, 100 units/ml penicillin and 100 mg/ml streptomycin. Transient and stable transfections were performed with Superfect Reagent (Qiagen, Valencia, CA, USA) according to the protocol provided by the manufacturer. Stable cell lines for expression of dopamine D2 receptors were selected with 1 mg/ml G-418 (Life Technologies), and screened for D2R expression by the [ 
Northern blots
Cells were lysed directly on the culture plates and total RNA was isolated with the RNeasy Mini kit (Qiagen). For each sample, 7 g RNA was used in Northern blot analysis. 11 Blots were hybridized with D2R 32 P-randomlabeled probe. After autoradiography, the blots were stripped and probed with 32 P-labeled single stranded DNA for GAPDH, to normalize for RNA loading. Dopamine D2 receptor-binding assay [ 3 H]Spiperone binding activity was used to measure D2R levels as described previously, 11 with some modifications. Cells suspensions were prepared by sonication. The supernatant from an 800 g centrifugation was diluted to 200 g protein/ml in assay solution. Samples (40 g of protein in 200 l of assay solution) were incubated for 30 min on ice with 1 nm [ 3 H]spiperone, either in the absence or presence of 6 m (+)butaclamol. GF/F glass filters were wetted with 0.9% NaCl before loading these incubation mixes on to the filters. After washing four times with ice cold wash solution (5 ml for each wash, using a 50 mm Tris-HCl pH 7.4 solution containing 150 mm NaCl), the filters were dried in the hood and then placed into scintillation vials for counting.
Dopamine modulation of forskolin-induced cyclic AMP levels
These experiments were performed essentially as described by Watts et al. 19 Cells grown in 12-well plates were preincubated for 10 min at 37°C with 500 l assay buffer (EBSS containing 0.02% ascorbic acid and 2% FBS). Drugs (10 m forskolin and 10 m dopamine) were added after cells were placed on ice. Cells were then returned to the 37°C incubator for 15 min. After removing the medium, the cells were lysed directly on 12-well plates with 1 ml boiling water containing 4 mm EDTA, and sonicated for 30 s. After centrifugation for 15 min at full speed in a benchtop centrifuge, protein concentrations in the supernatants were determined with the BioRad Protein Assay Reagent (BioRad Laboratories, Hercules, CA, USA). The cAMP levels in the cell extracts were measured with the cyclic AMP ( 3 H) assay system from Amersham, with some modifications. Depending on the cAMP levels in the extracts, 5 to 50 l of supernatant was used in the assay. GF/F glass microfiber filters (24 mm) were used to separate the protein-bound cyclic AMP from the unbound nucleotide. The filters were washed, dried and radioactivity was determined in the scintillation counter. cAMP levels in each sample were normalized for protein concentration.
MicroPET imaging
Recombinant adenoviruses were injected via the tail vein into 10-12-week-old male nude mice (nu/nu, 22-30 g; Charles River Breeding Laboratory, Wilmington, MA, USA), as described for each experiment. For measurement of D2R-dependent FESP retention or HSV1-sr39tk-dependent FHBG retention, mice were anesthetized by intraperitoneal injection of ketamine/xylazine [9] [10] [11] and injected via the tail vein with either FESP (150-250 Ci, 1000-2000 Ci/mmol) or FHBG (200-150 Ci, 1000-2000 Ci/mmol). After tracer uptake (3 h for FESP; 1 h for FHBG), mice were anesthetized and scanned in the prone position with the long axis of the mouse parallel to the long axis of the microPET scanner. Each scan required about 30 min (4 min per bed position, seven bed positions). All images were reconstructed using an iterative reconstruction technique. 32 
Quantitation of fluorine-18 retention in murine liver microPET image analysis
Regions of interest (ROI) were drawn over the liver image (left, front, and right lobes) on decay-corrected whole body coronal images of each mouse. [9] [10] [11] The counts per pixel/min obtained from the ROI were converted to counts per ml/min by using a calibration constant obtained from scanning a cylinder phantom in the microPET scanner. The ROI counts per ml/min were converted to counts per g/min, assuming a tissue density of 1 g/ml, and divided by the injected dose to obtain an image ROI-derived percent injected dose of fluorine-18 tracer retained per gram of liver (%ID/g liver).
